Rchr
J-GLOBAL ID:202001016577323780   Update date: Mar. 06, 2025

NAGASHIMA Takuya

ナガシマ タクヤ | NAGASHIMA Takuya
Affiliation and department:
Job title: Assistant Professor
Research field  (2): Pharmacology ,  Biological, health, and medical informatics
Research keywords  (6): Clinical pharmacology ,  Basic pharmacology ,  Pharmacoepidemiology ,  Pharmacodynamics ,  Clinical informatics ,  Molecular pharmacology
Papers (21):
  • Hayato Akimoto, Takuya Nagashima, Kimino Minagawa, Takashi Hayakawa, Yasuo Takahashi, Satoshi Asai. Non-Linear Dose-Response Relationship for Metformin in Japanese Patients With Type 2 Diabetes: Analysis of Irregular Longitudinal Data by Interpretable Machine Learning Models. Pharmacology Research & Perspectives. 2025. 13. 1
  • Yasuo Takahashi, Kimino Minagawa, Takuya Nagashima, Takashi Hayakawa, Hayato Akimoto, Satoshi Asai. Long-term benefit of SGLT2 inhibitors to prevent heart failure hospitalization in patients with diabetes, with potential time-varying benefit. Clinical and Translational Science. 2024. 17. 12
  • Kimino Minagawa, Takashi Hayakawa, Hayato Akimoto, Takuya Nagashima, Yasuo Takahashi, Satoshi Asai. Late development of OCD-like phenotypes in Dlgap1 knockout mice. Psychopharmacology. 2024
  • Takashi Hayakawa, Takuya Nagashima, Hayato Akimoto, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Benzodiazepine-related dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records. DIGITAL HEALTH. 2023. 9. 205520762311785
  • Hayato Akimoto, Takashi Hayakawa, Takuya Nagashima, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Detection of potential drug-drug interactions for risk of acute kidney injury: a population-based case-control study using interpretable machine-learning models. Frontiers in Pharmacology. 2023. 14. 1176096
more...
Lectures and oral presentations  (12):
  • An early and versatile detection scheme of adverse drug reactions using large-scale administrative claims data
    (The 96th Annual Meeting of the Japanese Pharmacological Society 2022)
  • Identifying antidepressants less likely to cause hyponatremia: triangulation of retrospective cohort, disproportionality, and pharmacodynamic studies
    (The 96th Annual Meeting of the Japanese Pharmacological Society 2022)
  • Identification of the therapeutic target for tendinopathy through the combination of real world data analysis and pharmacological experiments
    (The 96th Annual Meeting of the Japanese Pharmacological Society 2022)
  • 抗精神病薬による有害事象の軽減方法の探索: 臨床情報データベースを用いた時系列解析
    (第68回日本薬学会近畿支部総会・大会 2018)
  • Prevention of antipsychotic-induced hyperglycemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism
    (18th World Congress of Basic and Clinical Pharmacology 2018)
more...
Education (2):
  • - 2020 Kyoto University Graduate School of Pharmaceutical Sciences Division of Biomedical Sciences
  • - 2016 Kyoto University Faculty of Pharmaceutical Sciences Division of Pharmacy
Professional career (1):
  • 博士(薬学) (京都大学)
Awards (2):
  • 2023/12 - The 34th Japan Reserch Foundation for Clinical Pharmacology Academic Paper Award
  • 2022/12 - The 96th Annual Meeting of the Japanese Pharmacological Society Best Presentation Award
Association Membership(s) (2):
The Japanese Society of Clinical Pharmacology and Therapeutics ,  The Japanese Pharmacological Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page